The leaders ofthe St. Jude Comprehensive Cancer Center (SJCCC) are responsible for setting the Center's strategic goals and establishing a laboratory and clinical research environment that can realize its cancer focused mission. The SJCCC administrative staff provide logistical support to this mission;implementing the plans and policies established to ensure an efficient and productive Center. The Office of SJCCC Administration works closely with the SJCCC Director, Associate Directors of the SJCCC, the Center Program leaders, and Shared Resource Leaders to provide support for the functions required for efficient operation of all Center activities, including the day-to-day operations of the SJCCC Director's office. The Center administration works with the Director to develop and manage all fiscal activities;provide oversight of Center institutional and external funds;participate in the development and oversight of the research support infrastructure;develop, implement, and maintain policies and procedures;coordinate the submission of grants and related site visits;and serve as a liaison to and primary point of contact with both internal units and external agencies. Funding from the CCSG supports a percentage of the salary of the Center Administrator, the Director's Executive Associate, and other administrative staff.
The Office of Administration coordinates and manages services important for the efficient and productive functioning of the SJCCC. This role is crucial in the global effort to advance the research and treatment of pediatric malignant diseases.
|Penkert, Rhiannon R; Hurwitz, Julia L; Thomas, Paul et al. (2018) Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia. Haematologica 103:e50-e54|
|Turner, Benjamin L; Brenes-Arguedas, Tania; Condit, Richard (2018) Pervasive phosphorus limitation of tree species but not communities in tropical forests. Nature 555:367-370|
|Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063|
|Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263|
|Pui, Ching-Hon; Liu, Yiwei; Relling, Mary V (2018) How to solve the problem of hypersensitivity to asparaginase? Pediatr Blood Cancer 65:|
|Mukkada, Sheena; Smith, Cristel Kate; Aguilar, Delta et al. (2018) Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting. Pediatr Blood Cancer 65:|
|Buchman, Cameron D; Chai, Sergio C; Chen, Taosheng (2018) A current structural perspective on PXR and CAR in drug metabolism. Expert Opin Drug Metab Toxicol 14:635-647|
|Gibbs, E B; Kriwacki, R W (2018) Direct detection of carbon and nitrogen nuclei for high-resolution analysis of intrinsically disordered proteins using NMR spectroscopy. Methods 138-139:39-46|
|Howell, Carrie R; Wilson, Carmen L; Ehrhardt, Matthew J et al. (2018) Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study. Cancer 124:1036-1043|
|Zamora, Anthony E; Crawford, Jeremy Chase; Thomas, Paul G (2018) Hitting the Target: How T Cells Detect and Eliminate Tumors. J Immunol 200:392-399|
Showing the most recent 10 out of 6764 publications